Moderna (MRNA) Other Accumulated Expenses (2017 - 2026)
Moderna's Other Accumulated Expenses came in at $163 million for Q2 2026, down 15.1% from $192 million a year earlier and down 25.9% from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna's Other Accumulated Expenses was $185 million, down 16.3% from FY2024.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 40.3% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $221 million in FY2024 (+71.3%), $129 million in FY2023 (-48.2%), $249 million in FY2022 (+10.7%) and $225 million in FY2021 (+561.8%).
- The five-year range for quarterly Other Accumulated Expenses is $42 million (Q2 2024) to $553 million (Q3 2022).
- Year-over-year, Other Accumulated Expenses has declined for three consecutive quarters, with growth averaging 44.0% over the last eight quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2021 (growth of 561.8%), and the weakest in Q2 2024 (a decline of 82.2%).
- Business Quant data shows MRNA's Other Accumulated Expenses at $220 million (Q1 2026), $185 million (Q4 2025) and $73 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 163.00 Mn |
| Mar 31, 2026 | 220.00 Mn |
| Dec 31, 2025 | 185.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 192.00 Mn |
| Mar 31, 2025 | 252.00 Mn |
| Dec 31, 2024 | 221.00 Mn |
| Sep 30, 2024 | 69.00 Mn |
| Jun 30, 2024 | 42.00 Mn |
| Mar 31, 2024 | 190.00 Mn |
| Dec 31, 2023 | 129.00 Mn |
| Sep 30, 2023 | 239.00 Mn |
| Jun 30, 2023 | 236.00 Mn |
| Mar 31, 2023 | 212.00 Mn |
| Dec 31, 2022 | 249.00 Mn |
| Sep 30, 2022 | 553.00 Mn |
| Jun 30, 2022 | 409.00 Mn |
| Mar 31, 2022 | 240.00 Mn |
| Dec 31, 2021 | 225.00 Mn |
| Sep 30, 2021 | 252.00 Mn |
API Access
Moderna Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();